The Onco Cell Therapy Summit (OCTS) is the only industry-led meeting covering the full range of autologous and allogeneic cell product advancements. A four-tracked agenda, featuring pioneering biopharma, academia, and solution-providers, will address all innovative MoA, manufacturing challenges, and clinical progress of CAR T, TCR T, TILs, Macrophages, and NK cells in treating haematological and solid tumors. Expect to hear from CXOs, VPs, R&D and Process Developers on the opportunities generated from recent clinical and technological data, and how they are tackling the most pressing industry challenges to get effective treatments to patients.
Latest Past Events
Noble Life Sciences is Exhibiting at SOT 2022, 61st Annual Meeting. Noble Life Sciences is a preclinical CRO providing GLP Safety Toxicology Testing Services using small to large animal models to support small molecule, biologic, and cell and gene therapy products. Visit us at Booth # 2022 to discuss your safety toxicology testing needs. Schedule a meeting to learn how Noble can help in moving forward your toxicology program at an accelerated pace.
Noble Life Sciences Hosts Webinar “Live animal imaging in Oncology preclinical drug development” Speaker: Dr. Stephen Horrigan, Chief Scientific Officer, Noble Life Sciences Register Now Small animal optical imaging provides oncology researchers the ability to perform non-invasive longitudinal monitoring of disease progression, detection of metastasis and micro metastasis, and to accurately quantify tumor burden in a wide variety of animal models. This can be used to effectively monitor and quantitate responses to therapeutics and develop translational biomarkers that can be used throughout your drug development program. The sensitivity, versatility and non-invasive nature of combined luminescent and fluorescent imaging also [...]